Immuno-SPECT using 111In-labelled anti-TF 1849 IgG may become a unique imaging modality for the visualization of the biological characteristics of gliomas that is different from those obtained using the existing imaging modalities and may be useful to evaluate malignancy grade and determine sampling locations for biopsies in patients with glioma, particularly GBM. This evidence concerns the gene TF and central nervous system cancer.